Mar 6
|
Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks?
|
Mar 4
|
Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know
|
Mar 4
|
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
|
Feb 1
|
AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
|
Feb 1
|
Unlocking Q4 Potential of Amgen (AMGN): Exploring Wall Street Estimates for Key Metrics
|
Feb 1
|
Is Amgen Stock a Buy Now?
|
Jan 31
|
Amgen (AMGN) Stock Moves -0.11%: What You Should Know
|
Jan 30
|
Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Jan 29
|
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
|
Jan 29
|
Is Amgen a Good Dividend Stock to Buy Right Now?
|
Jan 29
|
Can Amgen (AMGN) Keep the Beat Streak Alive in Q4 Earnings?
|
Jan 29
|
deCODE genetics: A sequence variant that increases risk of pregnancy loss
|
Jan 27
|
Amgen's Planning to Take a Bite Out of Cancer. Here's What It Means for the Stock.
|
Jan 25
|
Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?
|
Jan 25
|
What To Watch: Novo Nordisk
|
Jan 25
|
The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson
|
Jan 24
|
Top Research Reports for Novartis, Amgen & Palo Alto Networks
|
Jan 23
|
5 Magnificent Dividend Growth Stocks to Buy and Hold Forever
|
Jan 22
|
Highlights From the 2024 JPMorgan Health Care Conference
|
Jan 22
|
Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy
|